Form 4: Invizyne Technologies CEO Buys Shares
Insider Transaction (Form 4)
Michael Heltzen, Chief Executive Officer of Invizyne Technologies Inc, purchased 855 shares of common stock on August 19, 2026.
Summary
- Open-market purchase: acquired 4 Common Stock at $7.58 ($30) on August 26, 2026; holds 14,708 after (Direct).
- Open-market purchase: acquired 251 Common Stock at $7.35 ($1,845) on August 26, 2026; holds 14,704 after (Direct).
- Open-market purchase: acquired 250 Common Stock at $7.60 ($1,900) on August 26, 2026; holds 14,453 after (Direct).
- Open-market purchase: acquired 250 Common Stock at $7.52 ($1,880) on August 25, 2026; holds 14,203 after (Direct).
- Open-market purchase: acquired 100 Common Stock at $7.50 ($750) on August 25, 2026; holds 13,953 after (Direct).
- Grant/award: acquired 8,841 Common Stock at $6.40 ($56,582) on August 19, 2026; holds 13,853 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $6,405, committing personal capital to the stock.
Insider Transactions
Michael Heltzen — Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-26 | Open-market purchase | Common Stock | 4 | $8 | $30 | 14,708 |
| 2026-08-26 | Open-market purchase | Common Stock | 251 | $7 | $1.8K | 14,704 |
| 2026-08-26 | Open-market purchase | Common Stock | 250 | $8 | $1.9K | 14,453 |
| 2026-08-25 | Open-market purchase | Common Stock | 250 | $8 | $1.9K | 14,203 |
| 2026-08-25 | Open-market purchase | Common Stock | 100 | $8 | $750 | 13,953 |
| 2026-08-19 | Grant/award | Common Stock | 8,841 | $6 | $56.6K | 13,853 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-26 | Open-market purchase (4 shares) |
| 2026-08-26 | Open-market purchase (251 shares) |
| 2026-08-26 | Open-market purchase (250 shares) |
| 2026-08-25 | Open-market purchase (250 shares) |
| 2026-08-25 | Open-market purchase (100 shares) |
| 2026-08-19 | Grant/award (8,841 shares) |
Keywords
insider transaction, Form 4, EXOZ, EXOZYMES INC., bullish, Michael Heltzen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.